Herein, we aimed to characterize the immune infiltration of HER2-negative early breast cancer according to HER2 expression by the 20-gene classifier and IHC categories, to explore associations with specific tumor-infiltrating immune cell (TIIC) populations overall and by HR status, and to evaluate implications for response to treatment. The gene discussed is ERBB2; the disease is neoplasm.